SB 709-FN (2020): relative to the definition of controlled drug analog.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “SB 709-FN (2020): relative to the definition of controlled drug analog.” Granite Record, https://graniterecord.org/bill/2020/sb709. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). SB 709-FN (2020): relative to the definition of controlled drug analog. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/sb709
- Chicago
- Granite Record. “SB 709-FN (2020): relative to the definition of controlled drug analog.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/sb709.
- BibTeX
@misc{bill-2020-sb709, title = {SB 709-FN (2020): relative to the definition of controlled drug analog.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/sb709}, note = {Accessed 24 Oct. 2026} }
SB 709-FN (2020)
relative to the definition of controlled drug analog.
- Status: Died on the table
- Term: 2019-2020
- House committee: Health, Human Services and Elderly Affairs
- Senate committee: Commerce
- Subject: Public and Mental Health
The Story
It was introduced on January 8, 2020 and referred to the Senate Commerce committee. The committee held a public hearing on January 28, 2020. The committee voted unanimously, 5–0, to recommend that the Senate pass it, and the report was placed on the consent calendar. On March 5, 2020 the Senate voted to pass it on a voice vote and ordered it to a third reading. It crossed to the House on March 12, 2020 and was referred to the House Health, Human Services and Elderly Affairs committee.
Sponsors
- Sen. Lou D'Allesandro (D - SD20) (prime sponsor)
- Sen. Cindy Rosenwald (D - SD13)
- Sen. Martha Hennessey (D - SD5)
- Sen. Bob Giuda (R - SD2)
- Sen. Kevin Cavanaugh (D - SD16)
Hearings and Sessions
- January 28, 2020, 2:00 PM: hearing, Senate Commerce, SH 100
Votes
- March 5, 2020, Senate: Ought to Pass — voice vote, passed
The Docket
- January 8, 2020: Introduced 01/08/2020 and Referred to Commerce
- January 28, 2020: Hearing: 01/28/2020, Room 100, SH, 02:00 pm
- March 5, 2020: Committee Report: Ought to Pass, 03/05/2020; Vote 5-0; CC
- March 5, 2020: Ought to Pass : MA, VV; OT3rdg; 03/05/2020
- March 12, 2020: Introduced 03/12/2020 and referred to Health, Human Services and Elderly Affairs
- June 30, 2020: Vacated and Laid on Table MA VV 06/30/2020
- September 23, 2020: Died on Table
Laws It Would Change
Related Bills
- SB 34-FN (2021): relative to the definition of a controlled drug analog and prohibiting the sale or possession of synthetic urine and urine additives.